Papillomavirus chimeric protein and application thereof
作者： Xuemei Xu , Zhirong Wang , Hongyang Liu , Yanying Xu , Liang Qiao
DOI:
关键词: Skeleton (computer programming) 、 Virology 、 Mutant 、 Fusion protein 、 Biology 、 L1 、 Infection induced 、 Human papillomavirus
摘要: Provided is a papillomavirus chimeric protein, the skeleton thereof being L1 protein or mutant thereof, at least one human 33-type L2 polypeptide embedded on skeleton. The present can be used for preparing vaccine preventing infections and infection induced disease.
lens.org 参考文章(14)
Brigitte Desiree Alberte Colau, Nicolas Pierre Fernand Lecrenier, Sandra Giannini, Najoua Dendouga, Guy Jean Marie Fernand Pierre Baudoux, Novel human papillomavirus (hpv) protein constructs and their use in the prevention of hpv disease ,(2010)
Bryce Chackerian, David S. Peabody, Immunogenic hpv l2-containing vlps and related compositions, constructs, and therapeutic methods ,(2011)
Diana V. Pastrana, John T. Schiller, Ratish Gambhira, Douglas R. Lowy, Richard B. S. Roden, Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies ,(2006)
Richard B. S. Roden, Subhashini Jagu, Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection ,(2008)
Kazunari Kondo, Tadahito Kanda, Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus ,(2008)
Christina Schellenbacher, Kihyuck Kwak, Dieter Fink, Saeed Shafti-Keramat, Bettina Huber, Christoph Jindra, Helena Faust, Joakim Dillner, Richard B.S. Roden, Reinhard Kirnbauer, Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses Journal of Investigative Dermatology. ,vol. 133, pp. 2706- 2713 ,(2013) , 10.1038/JID.2013.253
Kazunari Kondo, Hiroyuki Ochi, Tamae Matsumoto, Hiroyuki Yoshikawa, Tadahito Kanda, Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes Journal of Medical Virology. ,vol. 80, pp. 841- 846 ,(2008) , 10.1002/JMV.21124
Serge GlaxoSmithKline Biologicals S.A. Debrus, Martine Anne Cécile Wettendorff, Marie-Therese Martin, Robert John GlaxoSmithKline Stephen, Jean Glaxosmithkline Biologicals S.A. Stephenne, Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52 ,(2005)
Agnès Miseur, Emmanuel Mertens, Najoua Dendouga, Sarah Brendle, Karla K. Balogh, Neil D. Christensen, Sandra L. Giannini, Mathieu Boxus, Michel Fochesato, Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles Journal of Virology. ,vol. 90, pp. 6314- 6325 ,(2016) , 10.1128/JVI.00449-16
Ma Runlin, Chen Xiaojiang, Pronucleus preparation of nipple tumour virus capsid protein and application ,(2004)